Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home
309 items matching your search terms.
Filter the results.
Item type














New items since



Sort by relevance · date (newest first) · alphabetically
UNC scientists publish results from breast cancer survivors wellness workshops
by maryruth.helms published Feb 02, 2012 last modified Mar 06, 2013 08:57 AM — filed under: , ,
Scientists from UNC Lineberger have published a report describing an outreach program they developed for breast cancer survivors in four NC counties.
Located in News / 2012 News
UNC scientists recommend rethinking brain MRI for early-stage lung cancer patients
by maryruth.helms published Oct 10, 2011 last modified Oct 10, 2011 02:02 PM — filed under: , ,
UNC scientists report that in early stage, asymptomatic non-small cell lung cancer, early brain recurrences are potentially detectable prior to surgery and recommend that physicians consider including a routine pre-operative staging brain MRI. In addition, patients whose tumors are determined to be higher risk based on the findings at surgery, should consider post-operative MRI to offer early treatment of unrecognized metastasis.
Located in News / 2011 News
UNC spin-off receives $3M Small Business Innovation Research grant
by ellen.degraffenreid published Sep 30, 2011 last modified Oct 12, 2011 10:26 AM — filed under: , ,
Chapel Hill, NC – G-Zero Therapeutics, an RTP company started in 2008 based on technologies from the University of North Carolina at Chapel Hill, has been awarded a $3 million Phase II Small Business Innovation Research Grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
Located in News / 2011 News
UNC study highlights diagnosis of lung cancer subtypes
by maryruth.helms published May 17, 2012 last modified May 17, 2012 09:24 AM — filed under: , ,
In the processes of treating most cancers, one of the key pieces of information is the appearance of the tumor under the microscope using a technique called light microscopy. In lung cancer, for example, the appearance of the tumor determines both which chemotherapies are safe and which chemotherapies are effective. In addition, tumor appearance also suggests which patients should be tested for mutations that can be targeted by some of the most effective and safest drugs on the market.
Located in News / 2012 News
UNC study identifies pockets of high cervical cancer rates in North Carolina
by maryruth.helms published Mar 13, 2012 last modified Mar 14, 2012 11:22 AM — filed under: , ,
A study of cervical cancer incidence and mortality in North Carolina has revealed areas where rates are unusually high.
Located in News / 2012 News
UNC study looks at dose levels of the breast cancer drug, tamoxifen
by maryruth.helms published Jul 19, 2011 last modified Jul 19, 2011 01:54 PM — filed under: , , ,
Using a patient’s genetic information can be successfully used to manage the drug concentrations of tamoxifen, a drug used to treat and prevent breast cancer.
Located in News / 2011 News
UNC study shows potential for nanotechnology-based therapy for ovarian cancer
by maryruth.helms published Aug 30, 2011 last modified Aug 30, 2011 10:01 AM — filed under: , , ,
Chapel Hill - A UNC-led study has shown the potential for nanotechnology therapy for ovarian cancer. Scientists at UNC Lineberger Comprehensive Cancer Center and Duke University Medical Center conducted a preclinical study using nanoparticle technology to deliver doses of chemo- and radiotherapy that specifically targeted metastasized ovarian cancer cells, eradicating the cancer and lessening the toxicities often associated with the treatment.
Located in News / 2011 News
UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery
by maryruth.helms published May 02, 2012 last modified May 03, 2012 12:02 PM — filed under: , ,
Current nanomedicine research has focused on the delivery of established and novel therapeutics. But a UNC team is taking a different approach.
Located in News / 2012 News
UNC study: New genomic test may guide breast cancer treatment choices
by Susan Lucas published Feb 09, 2009 last modified Aug 10, 2011 11:28 AM — filed under: , , ,
UNC study: New genomic test may guide breast cancer treatment choices
Located in News / 2011 News
UNC surgeon trains future surgeons in Malawi: The Malawi Surgical Initiative
by maryruth.helms published Oct 05, 2011 last modified Oct 12, 2011 12:00 PM — filed under: ,
Carol Shores, MD, PhD, FACS, has been interested in the link between viruses and cancer for over 20 years, after working on virus- associated cancers as a pre-doctoral fellow in the UNC Department of Biochemistry and Biophysics. Oropharyngeal cancers, like cervical cancer, are associated with human papilloma viruses and endemic Burkitt lymphoma, a childhood cancer in sub-Saharan Africa, is associated with Epstein-Barr virus.
Located in News / 2011 News